Navigation Links
Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
Date:7/2/2009

WATERTOWN, Mass., July 2 /PRNewswire-USNewswire/ -- Last week, physicians, scientists, patients and members of the biotech industry from around the world gathered for the first major meeting of a unique research center on muscular dystrophy -- the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center.

Established last year and based at Boston Biomedical Research Institute (BBRI) in Watertown, MA, it is the only Wellstone Center and the only center in the world to focus solely on finding treatments and cures for the second most common adult form of MD known as facioscapulohumeral (FSH) muscular dystrophy. It is also the only Wellstone Center (there are five others in the US) in New England.

The purpose of the two-day retreat (June 16-18) was for world experts on this debilitating disease to present their current research findings, discuss and plan collaborative projects and fine-tune future research.

"We accomplished a great deal during this first gathering," said Dr. Charles Emerson, director of Boston Biomedical Research Institute and the Wellstone Center. "This was a wonderful opportunity to bring together the best minds involved in FSH research. We heard from individuals involved with this disease from Australia to Brazil to Iowa to Children's Hospital here in Boston. Their perspectives inform our direction moving forward."

FSH, which affects at least one in 20,000 adults worldwide, is characterized by a weakening of the skeletal muscles, beginning in the face and slowly progressing to the shoulder and upper-arm muscles and then down to the abdominal and foot-extensor muscles. In the worst cases, all skeletal muscles are lost, hearing and vision are involved, and respiratory insufficiency can cause severe disability.

The six Wellstone Centers -- inspired by and named for the late Senator Paul D. Wellstone and funded by the National Institutes of Health --represent a paradigm shift in research because of their intensely collaborative nature and especially because of their desire and mandate to include patient advocacy organizations as full partners in the research process.

Meeting participants came from BBRI, the FSH Society, Harvard, Acceleron and Novartis, Johns Hopkins Medical Institute, University of Maryland, University of Texas, Southwestern, University of Sao Paulo in Brazil, the University of Washington, and the FSH Global Research Foundation in Australia.

The Boston Biomedical Research Institute is a not-for-profit institution dedicated to the understanding, treatment, and prevention of specific human diseases such as muscular dystrophy, cancer, cardiovascular disease, and Alzheimer's. For more information, visit us on the web at www.bbri.org.


'/>"/>
SOURCE Boston Biomedical Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Study Shows Many Unplanned Quit Smoking Attempts are Successful
2. The Meetings Industry...Stirred But Not Shaken by Current Economic Setbacks - Patriot Meetings Announces Their 360 Degree Program that Ensures Successful Meetings
3. Women with cystic fibrosis can have safe and successful fertility treatment
4. Successful Demonstration of Health Information Exchange Opens ARRA Stimulus Options for California
5. Lenox Hill Heart and Vascular Institute of New York and Mentice, Inc. Announce the Successful Completion of Their 1st Trans-septal Cardiac Catheterization Training Course: A Comprehensive Hands-On Tutorial with Certification on June 12th and 13th 2009 in
6. Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic
7. Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound
8. Nationwide telemedicine networks are essential for successful health care reform
9. Palomar Successful in U.S. Patent Office Re-Examination of Hair Removal Patent
10. Havels Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada
11. Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
(Date:2/22/2017)... Colorado (PRWEB) , ... February ... ... the availability of their newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” ... delivery system®, which provides instant absorption from the mouth into the bloodstream. ...
(Date:2/22/2017)... WV (PRWEB) , ... February 22, 2017 , ... ... awarded a contract to Quality Insights to help small practices in Delaware, New ... Payment Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... communications company, launched a new media platform connecting healthcare technology professionals and other ... be followed by a quarterly publication starting on March 1, announced Michael J. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued to steadily ... the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, APOP also ... the benefits of corn and grains, value of raw and organic diets, and the ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... --  Known for selling everyday household products commonly found ... California urologist Dr. Ron ... the British conglomerate that makes those products – it ... her late husband,s invention, business plans, and other trade ... until his violent death in 2013, filed suit yesterday ...
(Date:2/22/2017)... Pharma announced today the completion of its executive management ... were added to form an executive team that will ... the implementation and administration of its newly executed strategic ... companies. Effective as of February ... following eight members reporting to Robert DiCrisci : ...
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
Breaking Medicine Technology: